“49. A SYSTEMATIC REVIEW OF HEALTH ECONOMIC EVALUATIONS OF PD-(L)1 INHIBITORS FOR FIRST-LINE TREATMENT AMONG PATIENTS WITH HIGH PD-L1 EXPRESSION NON-SMALL CELL LUNG CANCER” (2024) Tạp chí Y học Cộng đồng, 65(Tiếng Anh). doi:10.52163/yhc.v65i13.1891.